Harvard Bioscience, Inc. (HBIO) financial statements (2021 and earlier)

Company profile

Business Address 84 OCTOBER HILL RD
HOLLISTON, MA 01746
State of Incorp. DE
Fiscal Year End December 31
SIC 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments88667
Cash and cash equivalents88667
Receivables2121161618
Inventory, net of allowances, customer advances and progress billings2225212022
Inventory2225212022
Other current assets23444
Other undisclosed current assets    0
Total current assets:5458484551
Noncurrent Assets
Operating lease, right-of-use asset8
Property, plant and equipment56446
Intangible assets, net (including goodwill)96103575762
Goodwill5757403840
Intangible assets, net (excluding goodwill)3846171922
Regulated entity, other noncurrent assets  (0)(0) 
Other noncurrent assets22000
Other undisclosed noncurrent assets 0011
Total noncurrent assets:111111626270
TOTAL ASSETS:165169109108120
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities614101113
Accounts payable57569
Accrued liabilities 6554
Taxes payable11000
Deferred revenue4
Debt24322
Deferred revenue and credits111
Deferred tax liabilities   2
Other liabilities62011
Other undisclosed current liabilities71   
Total current liabilities:2522141519
Noncurrent Liabilities
Long-term debt and lease obligation555991116
Long-term debt, excluding current maturities475991116
Operating lease, liability8
Liabilities, other than long-term debt365107
Accounts payable and accrued liabilities 3133
Deferred tax liabilities, net2464
Deferred income tax liabilities2
Other liabilities1    
Total noncurrent liabilities:5864142123
Total liabilities:8386283643
Stockholders' equity
Stockholders' equity attributable to parent, including:8283817278
Common stock00000
Additional paid in capital229226219215211
Accumulated other comprehensive loss(13)(14)(11)(17)(12)
Accumulated deficit(125)(120)(117)(116)(112)
Other undisclosed stockholders' equity attributable to parent(11)(11)(11)(11)(11)
Total stockholders' equity:8283817278
TOTAL LIABILITIES AND EQUITY:165169109108120

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues116121102105109
Cost of revenue
(Cost of Goods and Services Sold)
(52)(58)(54)(56)(60)
Gross profit:6463484849
Operating expenses(64)(62)(48)(51)(50)
Operating income (loss):01(0)(3)(2)
Nonoperating expense(6)(9)(2)(0)(2)
Foreign currency transaction gain (loss), before tax 0(1)10
Other nonoperating expense(0)(4)(1)(0)(1)
Interest and debt expense(0)(5)(1)(1)(1)
Other undisclosed income from continuing operations before equity method investments, income taxes05111
Loss from continuing operations before income taxes:(6)(8)(2)(3)(4)
Income tax expense (benefit)141(1)(15)
Loss from continuing operations:(5)(4)(1)(4)(19)
Income from discontinued operations 1   
Net loss available to common stockholders, diluted:(5)(3)(1)(4)(19)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(5)(3)(1)(4)(19)
Other comprehensive income (loss)1(3)6(5)(4)
Comprehensive income (loss), net of tax, attributable to parent:(4)(6)5(9)(23)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: